UK markets open in 6 hours 36 minutes

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
123.46-3.67 (-2.89%)
At close: 04:00PM EDT
123.45 -0.01 (-0.01%)
After hours: 07:07PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
428,430
966,777
2,115,869
1,502,648
-
Other short-term investments
1,247,820
1,022,597
0
435,923
-
Total cash
1,676,250
1,989,374
2,115,869
1,938,571
-
Net receivables
400,327
214,628
152,990
100,870
-
Inventory
322,859
203,968
186,212
231,961
-
Other current assets
8,181
6,821
5,303
4,065
-
Total current assets
2,579,331
2,557,861
2,604,099
2,485,196
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
548,076
393,867
349,319
358,218
-
Accumulated depreciation
-190,970
-148,876
-112,632
-76,027
-
Net property, plant and equipment
357,106
244,991
236,687
282,191
-
Equity and other investments
6,527
31,321
34,892
38,799
-
Intangible assets
29,620
7,578
14,239
13,628
-
Other long-term assets
210,189
183,653
143,285
12,984
-
Total non-current assets
685,245
570,505
543,875
499,522
-
Total assets
3,264,576
3,128,366
3,147,974
2,984,718
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
105,483
-
-
-
-
Accounts payable
164,918
95,875
76,741
111,090
-
Taxes payable
13,766
12,521
216
-
-
Accrued liabilities
122,424
271,745
161,037
100,132
-
Deferred revenues
50,416
89,244
89,244
89,244
-
Other current liabilities
-
15,489
15,051
22,139
7,843
Total current liabilities
653,659
619,604
452,733
416,026
-
Non-current liabilities
Long-term debt
1,132,515
1,544,292
1,096,876
992,493
-
Deferred revenues
437,000
485,000
574,244
663,488
-
Other long-term liabilities
41,100
36,942
54,600
70,585
-
Total non-current liabilities
1,751,580
2,123,812
1,767,232
1,806,933
-
Total liabilities
2,405,239
2,743,416
2,219,965
2,222,959
-
Stockholders' equity
Common stock
9
9
9
8
-
Retained earnings
-4,446,213
-3,910,236
-3,206,748
-2,848,129
-
Accumulated other comprehensive income
918
-1,664
-20
3
-
Total stockholders' equity
859,337
384,950
928,009
761,759
-
Total liabilities and stockholders' equity
3,264,576
3,128,366
3,147,974
2,984,718
-